RayzeBio, Inc. (RYZB) Misses Q3 EPS by 57c

RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance